Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients
Authors:
Open Access
- 25 November 2003
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 89 (11) , 2027-2030
Abstract
The antinociceptive effect of morphine and oxycodone is mediated preferentially at μ and κ receptors, respectively. The aim of this study was to evaluate the analgesic profile of the combination of morphine and oxycodone in cancer pain, compared to the standard administration of morphine alone. Controlled-release formulations of oxycodone (CRO) and morphine (CRM) were compared in 26 patients. The study started with an open-label, randomised titration phase to achieve stable pain control for 7 days, followed by a double-blind, randomised crossover phase in two periods, 14 days each. At any point, patients were allowed to use oral immediate-release morphine (IRM) as needed, in order to keep visual analogue scale 4. Pain, satisfaction, adverse effects and number of daily rescue morphine tablets were assessed. A total of 22 patients were evaluated. The weekly upload consumption ratio in morphine/oxycodone was 1 : 1.8 (1.80, 1.83, 1.76, 1.84). The weekly IRM consumption was higher in patients having CRM compared to patients having CRO (ratio morphine/oxycodone: 1.6, 1.6, 1.6, 1.7) (P<0.05). Patients receiving oxycodone complained of less nausea and vomiting. The rescue morphine analgesic consumption was 38% higher in patients receiving only morphine, compared to patients receiving both morphine and oxycodone. The results suggest that the combination of morphine/oxycodone (opioids with differential preferential sites of action) can be a useful alternative to morphine alone, resulting in a better analgesia profile and less emesis.Keywords
This publication has 18 references indexed in Scilit:
- Heterologous µ‐opioid receptor adaptation by repeated stimulation of κ‐opioid receptor: up‐regulation of G‐protein activation and antinociceptionJournal of Neurochemistry, 2003
- Toleranzentwicklung unter Opioidgabe - Molekulare Mechanismen und klinische BedeutungAINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie, 2003
- Unwanted effects of morphine‐6‐glucuronide and morphineAnaesthesia, 2002
- Morphine or Oxycodone in Cancer Pain?Acta Oncologica, 2000
- The Relative Potency between High Dose Oral Oxycodone and Intravenous MorphineJournal of Pain and Symptom Management, 1999
- Size is everything – large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effectsPain, 1998
- Controlled‐release oxycodone compared with controlled‐release morphine in the treatment of cancer pain: A randomized, double‐blind, parallel‐group studyEuropean journal of pain, 1998
- The intrinsic antinociceptive effects of oxycodone appear to be κ -opioid receptor mediatedPain, 1997
- The Effect of Intrinsic Efficacy on Opioid ToleranceAnesthesiology, 1995
- A review of oxycodone's clinical pharmacokinetics and pharmacodynamicsJournal of Pain and Symptom Management, 1993